Ligand validation:6HR3

MBO: MERCURIBENZOIC ACID

MBO is a Ligand Of Interest in 6HR3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HR3_MBO_A_303	99%	52%	0.058	0.998	1.31	0.58	2	-	1	0	100%	0.7
6I0W_MBO_A_304	100%	49%	0.036	0.999	0.93	1.03	-	-	1	0	100%	0.77
6GM9_MBO_A_307	100%	51%	0.046	0.998	0.94	0.96	-	-	1	0	100%	0.84
4Q8Z_MBO_A_302	100%	14%	0.054	0.999	1.31	2.53	1	8	0	0	100%	1
4FU5_MBO_A_301	100%	17%	0.054	0.998	2.1	1.49	3	1	1	0	100%	0.7
6HXD_MBO_A_303	100%	48%	0.054	0.997	0.99	1.02	-	1	2	0	100%	0.78
6I1U_MBO_A_302	100%	47%	0.056	0.997	1.04	1.01	-	1	1	0	100%	0.79

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.